Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges
- PMID: 33029534
- PMCID: PMC7527887
- DOI: 10.1155/2020/9609731
Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges
Abstract
Liver-function decompensation or hepatocellular carcinoma (HCC) gradually appears after chronic hepatitis B progresses to cirrhosis. Effective antiviral treatment can significantly improve the long-term prognosis of decompensated patients, and some patients present recompensation of decompensated hepatitis B cirrhosis. At present, there are limited research data on the recompensation of decompensated hepatitis B cirrhosis. There is still controversy regarding the evaluation time, evaluation indicators, influencing factors, and long-term prognosis of recompensation.
Copyright © 2020 Hong Zhao et al.
Conflict of interest statement
All authors declare that they have no any conflict of interests.
References
-
- Geneva. World Health Organization; 2015. Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. - PubMed
-
- European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. Journal of Hepatology. 2018;69(2):406–460. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
